Principaux concurrents
Rendement du dividende (N) Rendement du dividende (N+1) PER (N) Price to Book (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Capi.($)
1,55 %1,73 %18.74x4.32x6.48x13.34x15.18x 62,53 Md
0,05 %0,1 %30.63x5.76x7.64x23.53x23.92x 52,43 Md
-.--%-.--%-12.71x1.13x4.47x-5.41x-4.26x 23,1 Md
-.--%-.--%-38.11x49.91x12.23x-36.05x-39.81x 21,4 Md
-.--%-.--%24.53x2.78x4.77x15.5x17.47x 17,76 Md
0,08 %0,12 %46.65x11.96x18.92x48.72x44.7x 15,47 Md
-.--%-.--%-734.33x18.15x34.85x-3923.62x-493.05x 14,68 Md
-.--%-.--%17.67x5.01x5.11x11.91x12.86x 14,08 Md
-.--%-.--%-27.59x29.78x25.44x-33.26x-26.93x 12,62 Md
-.--%-.--%-80.38x26.12x7.34x-60.78x-59.5x 11,73 Md
-.--%-.--%-11.34x40.45x2538.76x-13.45x-11.69x 10,98 Md
-.--%-.--%-34.72x9.38x - -31.7x-31.28x 9,23 Md
-.--%-.--%-6.42x - - -6.59x-6.05x 7,9 Md
-.--%-.--%11.44x5.62x7.16x11.48x10.63x 7,96 Md
0,16 %0,23 %51.06x1.83x3.94x17.75x32.93x 7,18 Md
0,42 %0,49 %16.97x5.02x - - - 7,24 Md
-.--%-.--%-18.78x21.97x733.79x-20.72x-17.5x 7,32 Md
Moyenne 0,13 % 0,16 % -43,92x 14,95x 243,64x -249,33x -33,27x 17,86 Md
Moyenne pondérée par Capi. 0,34 % 0,4 % -29,81x 12,53x 128,44x -191,65x -20,63x
Médicaments bio-thérapeutiques
🔇